BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okano M. Epstein-Barr virus infection and its role in the expanding spectrum of human diseases. Acta Paediatrica 1998;87:11-8. [DOI: 10.1111/j.1651-2227.1998.tb01377.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Okano M. Haematological associations of Epstein–Barr virus infection. Best Practice & Research Clinical Haematology 2000;13:199-214. [DOI: 10.1053/beha.1999.0068] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
2 Uchiyama T, Arai K, Yamamoto-tabata T, Hirai† K, Kishimoto K, Nakamura Y, Hattori T. Generalized myositis mimicking polymyositis associated with chronic active Epstein-Barr virus infection. J Neurol 2005;252:519-25. [DOI: 10.1007/s00415-005-0679-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
3 Prang N, Wolf H, Schwarzmann F. Latency of Epstein-Barr virus is stabilized by antisense-mediated control of the viral immediate-early gene BZLF-1. J Med Virol 1999;59:512-9. [DOI: 10.1002/(sici)1096-9071(199912)59:4<512::aid-jmv15>3.0.co;2-b] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
4 Hashimoto Y, Hashimoto N, Furuta S, Sugawara T, Kosugi N, Hata M, Eguchi M. A case of Epstein–Barr virus-associated natural killer/T-cell lymphoma presenting as dermatomyositis: extranodal relapse after 7 years in remission. Modern Rheumatology 2014;15:435-9. [DOI: 10.3109/s10165-005-0432-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Rugge M, Genta RM. Epstein-Barr virus: a possible accomplice in gastric oncogenesis. J Clin Gastroenterol 1999;29:3-5. [PMID: 10405221 DOI: 10.1097/00004836-199907000-00002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
6 Al-Salam S, John A, Daoud S, Chong SM, Castella A. Expression of Epstein-Barr virus in Hodgkin lymphoma in a population of United Arab Emirates nationals. Leuk Lymphoma 2008;49:1769-77. [PMID: 18661399 DOI: 10.1080/10428190802270894] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
7 Okano M, Gross TG. FROM BURKITT'S LYMPHOMA TO CHRONIC ACTIVE EPSTEIN-BARR VIRUS (EBV) INFECTION: An Expanding Spectrum of EBV-Associated Diseases. Pediatric Hematology and Oncology 2009;18:427-42. [DOI: 10.1080/088800101750476014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
8 Sughayer MA, Haddad HA, Al-Yousef RM, El-Khateeb M, Abu-Rass H. Epstein-Barr virus and Hodgkin lymphoma in Jordan. Hematol Oncol Stem Cell Ther 2014;7:85-9. [PMID: 24472289 DOI: 10.1016/j.hemonc.2013.12.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
9 Staege MS, Schneider J, Eulitz M, Scholz S, Bornkamm GW, Wölfel T, Reske-Kunz AB. Consequences of antigen self-presentation by tumor-specific cytotoxic T cells. Immunobiology 2000;201:332-46. [PMID: 10776790 DOI: 10.1016/s0171-2985(00)80088-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Okano M. Epstein-Barr virus in patients with immunodeficiency disorders. Biomed Pharmacother 2001;55:353-61. [PMID: 11669496 DOI: 10.1016/s0753-3322(01)00076-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
11 Carbone A, Gloghini A, Dotti G. EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist. 2008;13:577-585. [PMID: 18515742 DOI: 10.1634/theoncologist.2008-0036] [Cited by in Crossref: 175] [Cited by in F6Publishing: 147] [Article Influence: 12.5] [Reference Citation Analysis]
12 Sarid O, Anson O, Yaari A, Margalith M. Epstein-Barr virus specific salivary antibodies as related to stress caused by examinations. J Med Virol 2001;64:149-56. [DOI: 10.1002/jmv.1030] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
13 Zhang Y, Wang Y, Zhu C, Robertson ES, Cai Q. Role of SUMOylation in Human Oncogenic Herpesvirus Infection. Virus Res 2020;283:197962. [PMID: 32283130 DOI: 10.1016/j.virusres.2020.197962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Okano M, Gross TG. A review of Epstein-Barr virus infection in patients with immunodeficiency disorders. Am J Med Sci 2000;319:392-6. [PMID: 10875296 DOI: 10.1097/00000441-200006000-00009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
15 Kobayashi N, Mitsui T, Ogawa Y, Iriuchishima H, Takizawa M, Yokohama A, Saitoh T, Koiso H, Tsukamoto N, Murakami H, Nojima Y, Handa H. A Rare Case of Chronic Active Epstein-Barr Virus (EBV) Infection Accompanied by the Infiltration of EBV-infected CD8+ T Cells into the Muscle. J Pediatr Hematol Oncol 2018;40:e171-5. [PMID: 29200172 DOI: 10.1097/MPH.0000000000001026] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
16 Moffat LE. Infectious mononucleosis. Primary Care Update for OB/GYNS 2001;8:73-7. [DOI: 10.1016/s1068-607x(00)00078-0] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
17 Xu P, Yu D, Wang L, Shen Y, Shen Z, Zhao W. Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients. Ann Hematol 2015;94:239-47. [PMID: 25193354 DOI: 10.1007/s00277-014-2188-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
18 Okano M. Overview and problematic standpoints of severe chronic active Epstein–Barr virus infection syndrome. Critical Reviews in Oncology/Hematology 2002;44:273-82. [DOI: 10.1016/s1040-8428(02)00118-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
19 Iwatsuki K, Xu Z, Ohtsuka M, Kaneko F. Cutaneous lymphoproliferative disorders associated with Epstein-Barr virus infection: a clinical overview. J Dermatol Sci 2000;22:181-95. [PMID: 10698155 DOI: 10.1016/s0923-1811(99)00084-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
20 Kawa K, Okamura T, Yasui M, Sato E, Inoue M. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Crit Rev Oncol Hematol 2002;44:251-7. [PMID: 12467965 DOI: 10.1016/s1040-8428(02)00116-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
21 Okano M, Gross TG. A Review of Epstein-Barr Virus Infection in Patients with Immunodeficiency Disorders. The American Journal of the Medical Sciences 2000;319:392-6. [DOI: 10.1016/s0002-9629(15)40780-3] [Cited by in Crossref: 26] [Article Influence: 1.2] [Reference Citation Analysis]
22 Slots J. Interactions between Herpesviruses and Bacteria in Human Periodontal Disease. In: Brogden KA, Guthmiller JM, editors. Polymicrobial Diseases. Washington: ASM Press; 2002. pp. 317-31. [DOI: 10.1128/9781555817947.ch16] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
23 Nagasawa M, Hirai K, Mizutani S, Okawa H, Yata J. EBV infection induced transformation of benign T lymphoproliferative state in patient with chronic active EBV infection into malignant lymphoma: implication of EBV infection as additive oncogenic factor in tumorigenesis. Leukemia Research 1999;23:1071-8. [DOI: 10.1016/s0145-2126(99)00116-2] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
24 Sarid O, Anson O, Yaari A, Margalith M. Coping styles and changes in humoural reaction during academic stress. Psychology, Health & Medicine 2004;9:85-98. [DOI: 10.1080/13548500310001637779] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
25 Mosier DE. Epstein-Barr virus and lymphoproliferative disease. Curr Opin Hematol 1999;6:25-9. [PMID: 9915550 DOI: 10.1097/00062752-199901000-00005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]